≥99% Purity Verified by Third-Party Labs
    Free Shipping on Orders Over $100
    HPLC & Mass Spec 2X Tested
    Same Day Shipping on Orders Before 2PM EST Mon-Sat
    ≥99% Purity Verified by Third-Party Labs
    Free Shipping on Orders Over $100
    HPLC & Mass Spec 2X Tested
    Same Day Shipping on Orders Before 2PM EST Mon-Sat

    Research use only · Not for human or veterinary use

    ACE-031 research peptide - high purity lyophilized powder for laboratory research

    1MG

    $175
    3ml Vial
    In Stock
    Bulk Discounts

    Buy 3+ for $166.25 each and save 5%

    Buy 5+ for $157.50 each and save 10%

    Buy 10+ for $148.75 each and save 15%

    This product is for research purposes only. Not for human consumption.

    Purity: >98% (HPLC verified)

    Formulation: Lyophilized powder

    Molecular Formula: N/A (Fusion protein)

    Molecular Weight: ~58,000 g/mol

    CAS Number: N/A

    PubChem CID: N/A

    ACE-031

    Muscle Biology Research

    Overview

    This material is provided for controlled laboratory research and analytical characterization only.

    Mechanism of Action

    ACE-031 functions as a competitive inhibitor of multiple negative regulators of muscle mass. Its soluble ActRIIB domain has a high binding affinity for myostatin (GDF-8), a primary negative regulator of muscle growth. By binding myostatin in circulation, ACE-031 prevents the activation of ActRIIB receptors on muscle cell surfaces and the subsequent SMAD2/3 signaling pathways that inhibit muscle protein synthesis. The molecule also binds other TGF-β family members, including GDF-11 and activin A. The inhibition of myostatin signaling has been observed to increase the activation and proliferation of satellite cells. Downstream, this action leads to increased activity in the mTOR and Akt/PKB pathways and reduced expression of the muscle-specific E3 ubiquitin ligases atrogin-1 and MuRF1. The net result is a shift toward anabolism, leading to increases in muscle fiber size (hypertrophy) and potential increases in muscle fiber number (hyperplasia). The Fc domain extends the molecule's circulatory half-life by enabling it to bind to the neonatal Fc receptor (FcRn), which protects it from degradation.

    Research Findings

    Published nonclinical literature relevant to this material's molecular targets and experimental models is listed below for independent review. Findings involving other preparations or experimental systems should not be attributed to this research material.

    Research Applications

    • Duchenne muscular dystrophy research
    • Muscle wasting disorder models
    • Myostatin and GDF-11 inhibition research
    • TGF-β superfamily biology studies
    • Muscle growth signaling pathway research
    • Sarcopenia models
    • Muscle protein synthesis and degradation research
    • Satellite cell activation studies
    • ActRIIB receptor biology research
    • Muscle hypertrophy studies
    • Muscle regeneration research
    • Cachexia research

    Laboratory Handling & Limitations

    This material is supplied solely for in vitro and other nonclinical laboratory research. It is not for human or veterinary use, consumption, administration, therapeutic use, or diagnostic use.

    Laboratory Handling

    Handle only in an appropriately equipped laboratory using applicable institutional procedures, personal protective equipment, and the storage conditions shown for the material. The purchaser is responsible for study design, handling controls, disposal, and regulatory compliance.

    Research Limitations

    Published observations involving other preparations, experimental systems, or study populations do not establish the identity, performance, or suitability of this research material for any particular experiment.

    Scientific References

    Research Use Only

    This product is intended for research purposes only and is not for human consumption, therapeutic use, or diagnostic applications. Please ensure compliance with all applicable regulations and institutional guidelines.